JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 3,625 articles

Articles by James Calloway

UiPath Shares Gain Ahead of Critical AI-Focused Earnings Report
Earnings

UiPath Shares Gain Ahead of Critical AI-Focused Earnings Report

UiPath shares advanced 2.8% to $11.91 in Wednesday trading as investors positioned for quarterly results that will test the success of its strategic shift to an integrated AI automation platform.

PATH MSFT
Nu Holdings Shares Stagnate Amid Analyst Target Cuts, Global Expansion Plans
Earnings

Nu Holdings Shares Stagnate Amid Analyst Target Cuts, Global Expansion Plans

Nu Holdings shares were nearly unchanged in early trading as Bank of America reduced its price target, highlighting concerns over operating expenses and loan-loss provisions. The stock remains down sharply for the year despite the company reporting record quarterly profit.

NU PAGS INTR
NIO Posts First Quarterly Profit, Stock Jumps as 2026 Break-Even Target in Focus
Earnings

NIO Posts First Quarterly Profit, Stock Jumps as 2026 Break-Even Target in Focus

NIO shares rallied sharply after the company announced its first-ever quarterly net profit and forecast reaching break-even this year. The EV maker's Q4 revenue jumped 75.9% to 34.65 billion yuan.

NIO TSLA BYD FXI
Appeals Court Weighs State Social Media Bans, Snap Faces Teen Safety Scrutiny
Regulation

Appeals Court Weighs State Social Media Bans, Snap Faces Teen Safety Scrutiny

A federal appeals court heard arguments Tuesday on state laws limiting minors' social media access, placing Snapchat parent Snap Inc back in the legal spotlight. Judges questioned whether Florida's under-14 ban and Georgia's age verification rules could be invalidated.

SNAP META
NIO Posts First Quarterly Profit, Shares Surge on Strong Outlook
Earnings

NIO Posts First Quarterly Profit, Shares Surge on Strong Outlook

NIO achieved its first quarterly net profit in Q4, reporting 282.7 million yuan versus a year-ago loss. Revenue surged 75.9% to 34.65 billion yuan, driving shares up 15.2%.

NIO XPEV LI BYD FXI
AeroVironment Cuts Outlook After Space Force Contract Termination
Earnings

AeroVironment Cuts Outlook After Space Force Contract Termination

AeroVironment reduced its full-year revenue and earnings guidance following the U.S. government's decision to end the BADGER agreement tied to the Space Force's SCAR program. The company reported a net loss of $156.6 million for its fiscal third quarter.

AVAV
Accenture Shares Dip on Analyst Target Cut Ahead of Q2 Report
Earnings

Accenture Shares Dip on Analyst Target Cut Ahead of Q2 Report

Accenture shares declined following a price target cut by Truist, which highlighted concerns over enterprise AI adoption and partner spending ahead of the company's upcoming quarterly results.

ACN IBM CTSH
United Airlines Warns of Q1 Profit Hit as Jet Fuel Costs Soar
Earnings

United Airlines Warns of Q1 Profit Hit as Jet Fuel Costs Soar

United Airlines Holdings stock declined after the carrier warned rising jet fuel expenses will significantly impact first-quarter results, with TD Cowen projecting adjusted EPS could drop to as low as $0.05.

UAL DAL AAL JPM
Intuit Shares Slide on Spending Concerns Despite Analyst Upgrade
Earnings

Intuit Shares Slide on Spending Concerns Despite Analyst Upgrade

Intuit shares dropped nearly 4% Tuesday as investors focused on elevated spending forecasts overshadowing a bullish analyst upgrade and strong January-quarter results.

INTU ADBE CRM HRB
J&J Seeks Earlier Use of Tecvayli in Europe Following US Myeloma Approval
Regulation

J&J Seeks Earlier Use of Tecvayli in Europe Following US Myeloma Approval

Johnson & Johnson has submitted an application to European regulators to expand the use of its myeloma drug Tecvayli as a monotherapy after just one prior treatment. This follows recent U.S. approval for a Tecvayli combination and is supported by trial data showing a 71% reduction in disease progression risk.

JNJ BMY PFE
Teradyne Files German Copyright Suit Against Chinese Robotics Firm Elite Robots
Regulation

Teradyne Files German Copyright Suit Against Chinese Robotics Firm Elite Robots

Teradyne Robotics has initiated a copyright lawsuit in Germany against the German subsidiary of China's Elite Robots, claiming unauthorized use of Universal Robots software. The company also notified European safety authorities about potential issues with Elite Robots' machines.

TER
Exxon Mobil Seeks Shareholder Nod to Reincorporate in Texas
Regulation

Exxon Mobil Seeks Shareholder Nod to Reincorporate in Texas

Exxon Mobil Corporation has proposed shifting its legal headquarters from New Jersey to Texas, a move requiring shareholder approval at its upcoming annual meeting. The change would align its legal home with its operational hub but not affect physical assets or employment.

XOM